People Search
Phones, Emails, Addresses, Background check, Web references
All public info
Like other search engines (Google or Bing) Radaris collects information from public sources.
A new approach to pharmacogenomics. Yoshiji FUJITA Research Division, Glaxo Wellcome K.K., Ibaraki ３００‐４２４７, Japan Abstract: The medicine in the ２１st century will ...
Yoshiji Fujita, Ph.D. (President & CEO) Alun McCarthy, Ph.D. (Managing Director) Naoto Kagiyama, Ph.D. Fumiko Yoshii; Hideki Kagami, MBA; Kazuyuki Masuda, MBA, Ph.D.
Ｃｙｔｏ Pathfinder Agreement Concerning Joint Research of Ophthalmic drug March 22,2006—CytoPathfinder, Inc.(headquartered in Tokyo, Shinagawa, Japan, CEO: Yoshiji Fujita) and ...
Yoshiji Fujita. 158 Gene therapy - its present status and future direction. Teruhiko Toyo-oka. 163 Proposals for innovative pharmacology education from the ...
Dr. Yoshiji Fujita, Tokyo Medical College Dr. Osamu Nagayama, Chugai Pharmaceuticals (Tentative) Possibility of regenerative medicine with brain neural stem ...
A new approach to pharmacogenomics. Yoshiji FUJITA Research Division, Glaxo Wellcome K.K., Ibaraki , Japan Abstract: The medicine in the st ...
Dr. Yoshiji Fujita, Tokyo Medical College Dr. Osamu Nagayama, Chugai Pharmaceuticals (Tentative) Possibility of regenerative medicine with brain ...
Linkedin